von Willebrand disease: proposing definitions for future research
- PMID: 33496750
- PMCID: PMC7839375
- DOI: 10.1182/bloodadvances.2020003620
von Willebrand disease: proposing definitions for future research
Conflict of interest statement
Similar articles
-
Biology of inherited coagulopathies: von Willebrand factor.Hematol Oncol Clin North Am. 1992 Oct;6(5):1011-20. Hematol Oncol Clin North Am. 1992. PMID: 1400069 Review.
-
Diagnosis and incidence of inherited von Willebrand disease.Curr Opin Hematol. 2001 Sep;8(5):306-11. doi: 10.1097/00062752-200109000-00007. Curr Opin Hematol. 2001. PMID: 11604566
-
Current approaches to pregnancy and childbirth in women with von Willebrand disease.Clin Adv Hematol Oncol. 2018 Apr;16(4):254-257. Clin Adv Hematol Oncol. 2018. PMID: 29742079 No abstract available.
-
von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M.J Thromb Haemost. 2006 Sep;4(9):2088-90. doi: 10.1111/j.1538-7836.2006.02069.x. J Thromb Haemost. 2006. PMID: 16961623 No abstract available.
-
[Inborn and acquired von Willebrand disease].Hamostaseologie. 2008 Dec;28(5):312-9. Hamostaseologie. 2008. PMID: 19132162 Review. German.
Cited by
-
Predictors of diagnostic delays and loss to follow-up in women with von Willebrand disease: a single-center retrospective cohort study.Res Pract Thromb Haemost. 2024 Sep 12;8(6):102567. doi: 10.1016/j.rpth.2024.102567. eCollection 2024 Aug. Res Pract Thromb Haemost. 2024. PMID: 39391562 Free PMC article.
-
Epidemiological, Demographic, and Clinical Characteristics of Von Willebrand Disease Patients in Zahedan City, Iran: A Descriptive Study.Int J Hematol Oncol Stem Cell Res. 2024 Jul 1;18(3):220-226. doi: 10.18502/ijhoscr.v18i3.16102. Int J Hematol Oncol Stem Cell Res. 2024. PMID: 39257710 Free PMC article.
-
von Willebrand disease.Nat Rev Dis Primers. 2024 Jul 25;10(1):51. doi: 10.1038/s41572-024-00536-8. Nat Rev Dis Primers. 2024. PMID: 39054329 Review.
-
Tranexamic acid for management of heavy vaginal bleeding: barriers to access and myths surrounding its use.Res Pract Thromb Haemost. 2024 Mar 19;8(3):102389. doi: 10.1016/j.rpth.2024.102389. eCollection 2024 Mar. Res Pract Thromb Haemost. 2024. PMID: 38623473 Free PMC article.
-
Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies.Blood. 2024 Apr 4;143(14):1414-1424. doi: 10.1182/blood.2023022457. Blood. 2024. PMID: 38142407 Free PMC article.
References
-
- Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand’s disease. Blood. 1987;69(2):454-459. - PubMed
-
- Bowman M, Hopman WM, Rapson D, Lillicrap D, James P. The prevalence of symptomatic von Willebrand disease in primary care practice. J Thromb Haemost. 2010;8(1):213-216. - PubMed
-
- Castaman G, Lethagen S, Federici AB, et al. . Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD. Blood. 2008;111(7):3531-3539. - PubMed
